Santen Pharmaceutical Co., Ltd.
4536
Kedudukan dalam Saham
#4330
Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research,... Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addressing a variety of eye conditions. Its pipeline for glaucoma and ocular hypertension includes several key assets: DE-111, currently in Phase III clinical trials; DE-117, available for sale in Japan; DE-126, progressing through Phase IIb trials; DE-128, which is on the market in Europe and undergoing Phase II/III trials in the United States; and DE-130A, also in Phase III development. Beyond glaucoma, Santen's offerings extend to other ocular ailments. It provides DE-114A for allergic conjunctivitis and DE-076C for vernal keratoconjunctivitis. Furthermore, DE-109 is in Phase III clinical trials for the treatment of uveitis. The company is also active in addressing myopia with DE-127, currently in Phase II/III trials in Japan and Phase III in other Asian markets, alongside STN1013400, which is in Phase I trials. For dry eye, Santen offers DE-089C, which has successfully concluded its Phase III clinical trials. In addition to its prescription portfolio, the company produces and sells various over-the-counter (OTC) pharmaceutical products. Founded in 1890 under the name Santendo Pharmaceutical Co., Ltd., the company rebranded to its current name, Santen Pharmaceutical Co., Ltd., in 1958. It is headquartered in Osaka, Japan.
Harga Saham
$11.35
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$3.65B
Perubahan (1 hari)
1.55%
Perubahan (1 tahun)
-0.91%
Negara
JP
Perdagangan Santen Pharmaceutical Co., Ltd. (4536)
Kategori
Healthcare
Modal pasaran bagi Santen Pharmaceutical Co., Ltd.(4536)
Modal Pasaran: $3.65B
Sehingga October 2026, Santen Pharmaceutical Co., Ltd. mempunyai modal pasaran sebanyak $3.65B. Ini menjadikan Santen Pharmaceutical Co., Ltd. syarikat ke-4330th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Santen Pharmaceutical Co., Ltd. dari 2010 hingga 2026
4536 berbanding dengan 5 teratas yang paling popular stocks
